Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and Burkitt Lymphoma

pyrazolo(3,4-d)pyrimidine has been researched along with Burkitt Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Botta, M; Cozzi, M; D'Urso, V; De Falco, G; Forte, IM; Giordano, A; Giorgi, F; Indovina, P; Marcelli, E; Pentimalli, F; Schenone, S	1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Burkitt Lymphoma

Article	Year
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. Cell cycle (Georgetown, Tex.), 2012, Mar-01, Volume: 11, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Mitosis; Nuclear Proteins; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; src-Family Kinases	2012

Article

Year

Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.

Cell cycle (Georgetown, Tex.), 2012, Mar-01, Volume: 11, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Mitosis; Nuclear Proteins; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; src-Family Kinases

2012